General Updates

Wanbury Limited Re~d. Office : BSEL Tech Park, B-wing 10 Floor, Sector-30 A, Opp. Vashi Railway Station, Vashi Navi Mumbai 400 703 Maharashtra, INDIA Tel. : +91-22-6794 2222 WAN BURY +91-22-7196 3222 CIN LS 1900MH1988PLC048455 Email : info@wanbury.com Website : www.wanbury.com July 20, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex Mumbai -400 001. Bandra (East), Mumbai 400 051 Scrip Code: 524212 Scrip Code: W ANBURY Dear Sir, Sub.: Intimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Company's facility at Tanuku, West Godavari District, Andhra Pradesh We hereby notify that a routine current Good Manufacturing Practices (c GMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the company's facility at Tanuku, West Godavari District, Andra Pradesh during the period from July 13, 2026 to July 17, 2026. At the conclusion of the inspection, the U.S.FDA has issued a Form 483 with six observations. The Company will respond to these observations to FDA within the stipulated time. We will keep the stock exchanges informed if there is any further update in this matter. Please take the above information on record. Thanking you, Yours truly For Wanbury Limited Jitendra J Gandhi Company Secretary